A phase II randomized, double-blind, double-dummy, parallel group, placebo controlled study of THR-4109 in obese subjects
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2012
At a glance
- Drugs THR 4109 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 04 Jul 2008 Actual completion date July 2008, as reported by ClinicalTrials.gov.
- 04 Jul 2008 Status changed from in progress to complete as reported by ClinicalTrials.gov.
- 23 Jan 2008 The expected completion date for this trial is now 1 Jul 2008.